From: Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
Drugs | Molecular targets |
---|---|
Ceritinib | ALK |
ROS | |
Capmatinib | MET |
Lapatinib | ERBB2 |
EGFR | |
Nilotinib | KIT |
PDGFRA | |
CSF1R | |
Trametinib | KRAS, NRAS, HRAS |
PTPN11 | |
NF1 | |
MAP 2 K | |
Trametinib + Dabrafenib | BRAF |
Durvalumab + Olaparib | PDL1 |
PARP | |
Palbociclib | CDK4 |
CDK6 | |
Glasdegib | SMO |
TAS-120 | FGFR |